Tyra Biosciences Inc (NASDAQ: TYRA) is -42.13% lower on its value in year-to-date trading and has touched a low of $6.42 and a high of $29.60 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The TYRA stock was last observed hovering at around $10.05 in the last trading session, with the day’s loss setting it -0.05%.
Currently trading at $10.0, the stock is 0.75% and 1.12% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.21 million and changing -0.50% at the moment leaves the stock -28.87% off its SMA200. TYRA registered -28.06% loss for a year compared to 6-month loss of -28.06%.
The stock witnessed a 3.63% gain in the last 1 month and extending the period to 3 months gives it a 15.61%, and is 1.73% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 7.52% over the week and 7.67% over the month.
Tyra Biosciences Inc (TYRA) has around 60 employees, a market worth around $531.78M and $0.00M in sales. Distance from 52-week low is 55.76% and -66.22% from its 52-week high. The company has generated returns on investments over the last 12 months (-29.29%).
The EPS is expected to shrink by -40.21% this year
The shares outstanding are 53.09M, and float is at 32.07M with Short Float at 16.40%.
The top institutional shareholder in the company is RA CAPITAL MANAGEMENT, L.P. with over 10.42 million shares valued at $166.56 million. The investor’s holdings represent 17.755 of the TYRA Shares outstanding. As of 2024-06-30, the second largest holder is BOXER CAPITAL, LLC with 6.45 million shares valued at $103.11 million to account for 10.9911 of the shares outstanding. The other top investors are BVF INC/IL which holds 4.66 million shares representing 7.9449 and valued at over $74.53 million, while CANAAN PARTNERS XI LLC holds 7.5168 of the shares totaling 4.41 million with a market value of $70.52 million.
Tyra Biosciences Inc (TYRA) Insider Activity
The most recent transaction is an insider sale by KAPLAN GILLA, the company’s Director. SEC filings show that KAPLAN GILLA sold 9,568 shares of the company’s common stock on Jun 18 ’25 at a price of $9.78 per share for a total of $93596.0. Following the sale, the insider now owns 28231.0 shares.
Tyra Biosciences Inc disclosed in a document filed with the SEC on Jun 17 ’25 that KAPLAN GILLA (Director) sold a total of 10 shares of the company’s common stock. The trade occurred on Jun 17 ’25 and was made at $10.35 per share for $104.0. Following the transaction, the insider now directly holds 37799.0 shares of the TYRA stock.
